HOTH vs LEN · rev $1.24B vs rev $34.19B
Hoth Therapeutics Inc (HOTH) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Hoth Therapeutics Inc (HOTH) is a biotechnology company listed on US.
LEN (LEN) common stock.
Latest reported HOTH revenue for 2024-03-31 was $1.24B. Net income was -$2.1M. HOTH currently screens at market cap $15.5M.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
HOTH currently screens at market cap $15.5M. LEN currently screens at market cap $0.
Not investment advice. Open the HOTH and LEN stock pages for the full models.
Not investment advice.